Sun Pharmaceutical to acquire US company Concert for $576 million
Sun Pharmaceutical has agreed to acquire Concert for $576 million to gain access to the American company’s experimental drug for skin conditions and partial hair loss. Sun Pharmaceutical Industries Ltd
